Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Open: May 25, 14:23 PM 2012  
RIDBX IFABX CIMEX CIMCX RIDGX IFAFX 
 
 
  NYSE  7,549  3.591  Index Moved Down 



Processing
Collecting data for BPTH and ARDM ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Biopath Holdings Inc  and   Aradigm Corp.
Check Correlation Matrix  
Daily Returns (%)
BPTH  ARDM  
Timeline
Assuming 30 trading days horizon, Biopath Holdings Inc is expected to generate 2.14 times more return on investment than Aradigm. However, Biopath is 2.14 times more volatile than Aradigm Corporation. It trades about 0.16 of its potential returns per unit of risk. Aradigm Corporation is currently generating about 0.1 per unit of risk. If you would invest 27.00 in Biopath Holdings Inc on April 25, 2012 and sell it today you would earn a total of 7.00 from holding Biopath Holdings Inc or generate 25.93% return on investment over 30 days.

Diversification

Good diversification
Overlapping area represents amount of risk that can be diversified away by holding Biopath Holdings Inc and Aradigm Corp. in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

-0.18
 Parameters
Time Period1 Month [change]
DirectionNegative BPTH.OB Moved Down vs ARDM.OB
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between BPTH and ARDM with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between BPTH and ARDM to your reader
 
Get social with Correlation between BPTH and ARDM
 Share Correlation between BPTH and ARDM 
Share Share Correlation between BPTH and ARDM
    
    
 
       
Predicted Return Density
Expected Daily Returns   
BPTH  ARDM  

Biopath Holdings Inc

 
    
    
Biopath
Performance
6
Out Of
100
Over 30
Days
94% of all equities and portfolios perform better than Biopath Holdings Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Biopath Holdings Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 30 days.
    
    
Valeant Pharmaceuticals International Inc. vs. Biopath Holdings Inc
Elan Corporation plc vs. Biopath Holdings Inc
Hospira Inc. vs. Biopath Holdings Inc
Alkermes Inc. vs. Biopath Holdings Inc
PetMed Express Inc. vs. Biopath Holdings Inc
Acura Pharmaceuticals Inc. vs. Biopath Holdings Inc
  

Aradigm Corporation

 
    
    
Aradigm
Performance
4
Out Of
100
Over 30
Days
96% of all equities and portfolios perform better than Aradigm Corporation. Compared with the overall equity markets, risk-adjusted returns on investments in Aradigm Corporation are ranked lower than 4 (%) of all global equities and portfolios over the last 30 days.
    
    
Valeant Pharmaceuticals International Inc. vs. Aradigm Corporation
Elan Corporation plc vs. Aradigm Corporation
Hospira Inc. vs. Aradigm Corporation
Alkermes Inc. vs. Aradigm Corporation
PetMed Express Inc. vs. Aradigm Corporation
Acura Pharmaceuticals Inc. vs. Aradigm Corporation
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting